Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
about
Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumorsEarly and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerHow to Improve Therapeutic Ratio in Radiotherapy of HCCLiver-Directed Radiotherapy for Hepatocellular CarcinomaOligometastasis and oligo-recurrence: more than a mirageReview and uses of stereotactic body radiation therapy for oligometastasesRole of stereotactic body radiation therapy for hepatocellular carcinomaMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Diagnostic and therapeutic management of hepatocellular carcinomaResection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the LiteratureRadiation therapy has been shown to be adaptable for various stages of hepatocellular carcinomaSystematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.Curative stereotactic robotic radiotherapy treatment for extracranial, extrapulmonary, extrahepatic, and extraspinal tumors: technique, early results, and toxicity.Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.Strategies to tackle the challenges of external beam radiotherapy for liver tumorsThe efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesBone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results.Radiation therapy for liver tumors: ready for inclusion in guidelines?Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapyAnatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?Minimally invasive local therapies for liver cancerStereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicityStereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.Locally ablative therapies for primary and metastatic liver cancer.Radiation-associated liver injury.Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastasesStereotactic radiation therapy for liver metastases: factors affecting local control and survivalMulticentre results of stereotactic body radiotherapy for secondary liver tumours.Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases.Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.Cyberknife treatment for advanced or terminal stage hepatocellular carcinomaPrognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.
P2860
Q21129307-CE17BDE7-9795-4DDE-902C-D19DF95B5843Q24197545-B10591D6-066E-472B-B093-88D0C4DFA084Q26738862-A7AAF048-ED26-4171-B69D-46891E7A92B9Q26738869-09AB65F3-EDF4-42AF-8E5C-BBFBCCDC8F3BQ26828767-D5E6BEC8-BC33-4EDE-9C58-3151DD78DED7Q26864247-8530403F-69BB-446F-A0CD-6BE345008C6BQ26864969-A61739BC-FE6B-4675-B33E-E0040399A839Q26998606-6243CCF8-60D9-4C83-8B17-9455C86712B1Q26999043-25C649D1-B890-48D0-A977-20BC6F08C44AQ28079913-C448740C-9F86-44ED-899D-0DA112F29230Q28084869-6488F705-4BAE-48C9-AFAA-E98A29DE8434Q32173610-0C316B04-586F-4046-84CD-09D99C40D165Q33305385-33FEEEE3-99D8-4C77-B264-412C88341F78Q33682891-E1C082A0-E0C6-4A6A-9790-6960E36CBBFFQ33692477-81DA0446-F3A8-4384-97C3-14BC5536FE09Q33706721-C28B44EE-0F11-428E-938C-2FD670CCDEB0Q33746887-5602CCC3-1FE8-4C20-929A-A6853339D0AEQ33769424-B5CBFD2F-41C5-4A99-B5DD-33AF832345F4Q33818431-EB309850-D966-4758-BDC2-84650C3B039DQ34002010-F95C0167-2668-4527-A004-4246441D7B39Q34005194-BB075920-6F9F-4C50-94BD-2FFB1A6D2842Q34461833-2C4F73F4-893F-4972-82EA-978B8F3ECC64Q34548169-F9681D89-3544-44AF-ADF8-D4A4B5647F17Q34974386-3A1443BF-0C1D-4E3D-9E53-E46EA6E0C30DQ35023155-2B4B50AD-6EA1-446B-9C98-5CDCF5ABED6AQ35047457-10AC05D3-4755-43E0-8FC9-ACCFEE4488B3Q35152457-8DCA5BC9-3A07-4B64-9AD5-68104C50CF7AQ35297759-CCCA3796-DE9F-402B-95B0-616513841AB9Q35677877-EDC2277E-A9A6-4426-946E-FECF33B2B78AQ35731820-460E2E0F-DAD0-4F9F-8AB0-2E81705756B7Q35854741-74343621-4C40-46E9-96F5-138C33EA90CDQ35872656-53EC4DF3-81A7-4072-A5B8-FE67C955B203Q35971464-18945BB0-32A2-415A-B2B3-23841E8393F8Q36074220-57D6179D-4861-4AFE-834C-F69B7250819BQ36181619-D0618B71-E852-4426-BD00-E91EF73ABC46Q36201159-8AF84657-516F-47BF-9C91-C22EB3DCA38EQ36249520-55F781FF-D823-4687-AB83-CB9AAA288B27Q36360066-7E31A052-4AA7-4986-A2F9-633F4DED3BC9Q36360832-DAF85B27-B5EF-4FBE-9055-49EA3E52B809Q36388360-2B724CD6-1BAC-4C25-BD43-E5472C34C01B
P2860
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Stereotactic body radiation th ...... institution phase i-ii study.
@ast
Stereotactic body radiation th ...... institution phase i-ii study.
@en
Stereotactic body radiation th ...... institution phase i-ii study.
@nl
type
label
Stereotactic body radiation th ...... institution phase i-ii study.
@ast
Stereotactic body radiation th ...... institution phase i-ii study.
@en
Stereotactic body radiation th ...... institution phase i-ii study.
@nl
prefLabel
Stereotactic body radiation th ...... institution phase i-ii study.
@ast
Stereotactic body radiation th ...... institution phase i-ii study.
@en
Stereotactic body radiation th ...... institution phase i-ii study.
@nl
P2093
P2860
P1433
P1476
Stereotactic body radiation th ...... institution phase i-ii study.
@en
P2093
Alejandra Méndez Romero
Ben J M Heijmen
Cees Verhoef
Jan N M Ijzermans
Joost J Nuyttens
Peter C J M Nowak
Peter C Levendag
Rene P Brandwijk
Shahid M Hussain
Wouter Wunderink
P2860
P304
P356
10.1080/02841860600897934
P577
2006-01-01T00:00:00Z